📊 Evidence-Based Reference

Gore Excluder Conformable Aaa Endoprosthesis Excc

W. L. Gore & Associates, Inc.

Product: GORE EXCLUDER Conf AAA Endo - Trunk-Ipsilateral — all models and sizes

Contact a rep Compare similar devices

Summary: The Gore Excluder Conformable AAA Endoprosthesis is a stent-graft designed for endovascular aneurysm repair (EVAR) in patients with challenging aortic neck anatomies. Key evidence highlights its adaptability and efficacy in reducing complications like endoleaks.

FDA Clearance Information

Pathway ? PMA
Number ? P200030 ↗
Decision Date ? November 2, 2023
Product Code ? MIH System, Endovascular Graft, Aortic Aneurysm Treatment
Device Class ? Class 3
Evidence ? 40 studies

The Gore Excluder Conformable AAA Endoprosthesis received FDA premarket approval (PMA) on November 2, 2023. Manufactured by W. L. Gore And Associates, it is classified as a Class III medical device.

What It Is

The Gore Excluder Conformable AAA Endoprosthesis is a flexible stent-graft system used in endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAA). It is designed to conform to challenging aortic neck anatomies, improving graft fixation and reducing the risk of complications.

FDA-Cleared Indications

  • Treatment of abdominal aortic aneurysms using endovascular aneurysm repair.
  • Use in patients with aortic anatomy that meets the device's approved anatomic and sizing requirements.
  • Implementation of approved changes to manufacturing stations for the delivery system.

Clinical Applications

  • Endovascular repair of infrarenal abdominal aortic aneurysms.
  • Treatment of selected AAAs with challenging proximal aortic neck anatomy when the anatomy falls within the product labeling.
  • Exclusion of an abdominal aortic aneurysm from blood flow using a modular endovascular graft and iliac limb components.
  • Treatment of patients considered appropriate for endovascular repair rather than open surgical repair.

Reported off-label uses

  • Use outside the manufacturer's specified aortic neck length, diameter, angulation, or iliac access and landing-zone requirements.
  • Use in selected juxtarenal or more proximally located aortic aneurysms when standard infrarenal EVAR instructions for use are not met.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The available literature includes 13 studies, comprising various study types such as RCTs, prospective, and retrospective analyses, conducted between 2024 and 2025. These studies focus on the device's performance in challenging anatomical scenarios.

Reported Outcomes

Published studies report that the Gore Excluder Conformable AAA Endoprosthesis demonstrates effective aneurysm exclusion and reduced incidence of type I and III endoleaks. The device's adaptability to hostile neck anatomies has been associated with improved aortic remodeling and distal sealing.

Safety Profile

Reported complications include stent graft migration and type I endoleaks, particularly in cases with extreme anatomical challenges. However, the device's design aims to mitigate these risks by enhancing conformability and fixation.

Evidence Limitations

Current evidence is limited by short to mid-term follow-up periods and a focus on specific anatomical challenges. Further research is needed to evaluate long-term outcomes and broader applicability across diverse patient populations.

Practical Considerations

  • Device selection depends on preoperative CT angiography, including aortic neck diameter and length, neck angulation, aneurysm morphology, iliac landing zones, and access-vessel size.
  • The system is modular and requires compatible main-body and iliac limb components selected according to the manufacturer's sizing instructions.
  • Delivery is performed through femoral or iliac arterial access under fluoroscopic imaging, usually with local anesthesia and sedation or general anesthesia.
  • Follow-up imaging is required after EVAR to evaluate graft position, aneurysm sac behavior, limb patency, and possible endoleak or migration.
  • MRI conditions, including field strength and specific device configuration, should be confirmed in the current manufacturer labeling before scanning.

Linked Studies (20)

PubMed • 2026

Long Term Real World Performance of the Gore Excluder AAA Endoprosthesis Featuring the C3 Delivery System: Ten Year Results from the European C3 Module of the GREAT Registry.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Mid-Term Outcomes of EVAR in Hostile Neck Anatomy: Impact of Graft Adaptability on Type III Endoleak, Aortic Remodeling, and Distal Sealing.

Journal of clinical medicine

View Source →
PubMed • 2025

Conformable Endovascular Aneurysm Repair (EVAR) Stability in Hostile Neck Abdominal Aortic Aneurysms: A Single-Center Experience.

Cureus

View Source →
PubMed • 2025

Early results from the pivotal trial substudy of the GORE EXCLUDER conformable endoprosthesis in angulated necks.

Journal of vascular surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

British Society of Endovascular Therapy ConformabLe EndoVascular Aneurysm Repair Registry: An Analysis of Aortic Neck Coverage of the GORE® EXCLUDER® Conformable AAA Endoprosthesis With ACTIVE CONTROL System.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Inflammatory Aneurysm of the Common Iliac Artery With Elevated Serum Levels of Immunoglobulin G4 Manifesting After Endovascular Aneurysm Repair: A Case Report.

Cureus

View Source →
PubMed • 2025

One-year outcomes from the pivotal trial of a four-branch off-the-shelf solution to treat pararenal and extent IV thoracoabdominal aortic aneurysms.

Journal of vascular surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Wire wrap involving the celiac and superior mesenteric artery portals of the GORE EXCLUDER thoracoabdominal branch endoprosthesis: A multi-center case series.

Journal of vascular surgery cases and innovative techniques

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Total transfemoral approach for Gore Excluder thoracoabdominal branch endoprosthesis (TAMBE), external tour de graft technique.

Journal of vascular surgery cases and innovative techniques

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Component use of the GORE TAG thoracic branch endoprosthesis, GORE TAG conformable thoracic stent graft, GORE EXCLUDER thoracoabdominal branch endoprosthesis, and GORE EXCLUDER iliac branch endoprosthesis for the treatment of an extent II thoracoabdominal aortic aneurysm.

Journal of vascular surgery cases and innovative techniques

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Three-year outcomes of a US pivotal trial substudy for conformable endoprosthesis in ≥10 mm nonangulated neck anatomy.

Journal of vascular surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

Long-term Outcomes of the Endurant and Excluder Stent Grafts for Endovascular Aneurysm Repair in a Japanese Cohort.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

Use of real-world data and clinical registries to identify new uses of existing vascular endografts: combined use of GORE EXCLUDER Iliac Branch Endoprosthesis and GORE VIABAHN VBX Balloon Expandable Endoprosthesis.

BMJ surgery, interventions, & health technologies

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

Emergent endovascular treatment options for thoracoabdominal aortic aneurysm.

Seminars in vascular surgery

View Source →
PubMed • 2023

Technical pitfalls and proposed modifications of instructions for use for endovascular aortic aneurysm repair using the Gore Excluder conformable device in angulated and short landing zones.

Journal of vascular surgery cases and innovative techniques

Case Series View Source →
PubMed • 2022

One-year results of the GORE EXCLUDER Conformable AAA Endoprosthesis system in the United States regulatory trial.

Journal of vascular surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Excluder Stent Graft-Related Outcomes in Patients with Aortic Neck Anatomy Outside of Instructions For Use (IFU) within the Global Registry for Endovascular Aortic Treatment (GREAT): Mid-term Follow-Up Results.

Annals of vascular surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Protocol for GUo's renovisceral Artery reconstruction-1: a prospective, multicentre, single-arm clinical trial to evaluate the safety and efficacy of a multibRANched sTEnt graft systEm for thoracoabdominal aortic aneurysm (GUARANTEE study).

BMJ open

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Outcomes of Gore iliac branch endoprosthesis with internal iliac component versus Gore Viabahn VBX.

Journal of vascular surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2021

Comparison of anatomic feasibility of three different multibranched off-the-shelf stent-grafts designed for thoracoabdominal aortic aneurysms.

Journal of vascular surgery

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What are the clinical indications for Gore Excluder Conformable AAA Endoprosthesis?

The device is indicated for endovascular repair of abdominal aortic aneurysms, especially in patients with hostile neck anatomies.

What outcomes have been reported in clinical studies?

Studies have reported effective aneurysm exclusion, reduced type I and III endoleaks, and improved aortic remodeling.

What complications have been reported?

Safety data indicate potential complications such as stent graft migration and type I endoleaks, particularly in challenging anatomies.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you